Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia

Hematol Oncol. 2017 Jun;35(2):244-245. doi: 10.1002/hon.2254. Epub 2015 Aug 27.

Authors

Zuzana Sustkova¹, Ivana Jeziskova¹, Dana Dvorakova^{1

2}, Ondrej Horky¹, Lukas Semerad¹, Barbora Weinbergerova¹, Martin Culen², Jiri Mayer^{1

2}, Zdenek Racil^{1

2}

Affiliations

¹ Department of Internal Medicine, Haematology and Oncology, University Hospital Brno, Brno, Czech Republic.
² Faculty of Medicine, Masaryk University, Brno, Czech Republic.

PMID: 26310695
DOI: 10.1002/hon.2254

No abstract available

Publication types

Letter

MeSH terms

Aged
Cytarabine / administration & dosage
Daunorubicin / administration & dosage
Female
Histocompatibility Testing*
Humans
Induction Chemotherapy / methods
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation*

Substances

Cytarabine
Daunorubicin